Needham & Company
-
NextCure to Present at 21st Annual Needham Virtual Healthcare Conference
-
NextCure to Present at 21st Annual Needham Virtual Healthcare Conference
-
Needham & Company Reiterates NextCure (NXTC) at Buy, Focus Remains on Upcoming Results of Yale Study
-
NextCure Inc. (NXTC) PT Lowered to $14 at Needham & Company
-
NextCure to Present at the 20th Annual Needham Virtual Healthcare Conference
-
NextCure to Present at the 20th Annual Needham Virtual Healthcare Conference
-
NextCure to Present at the 19th Annual Needham Virtual Healthcare Conference
-
NextCure to Present at the 19th Annual Needham Virtual Healthcare Conference
-
Needham & Company Starts NextCure Inc. (NXTC) at Buy
-
NextCure Announces Closing of Public Offering
-
NextCure Announces Closing of Public Offering
-
NextCure Inc. (NXTC) Prices 4.077M Share Common Offering at $36.75/Sh
-
NextCure Announces Pricing of Public Offering of Common Stock
-
NextCure Announces Pricing of Public Offering of Common Stock
-
NextCure Inc. (NXTC) to Offer 3.2M in Stock
-
NextCure Announces Proposed Public Offering of Common Stock
-
NextCure Announces Proposed Public Offering of Common Stock

